The clinical and endocrine effects of 4-hydroxyandrostenedione alone and in combination with goserelin in premenopausal women with advanced breast cancer.

The aromatase inhibitor, 4-hydroxyandrostenedione (4OHA) is an effective treatment for advanced post-menopausal breast cancer. The clinical and endocrine effects of 4OHA treatment were studied in five pre- and perimenopausal women with metastatic breast cancer. Serum oestradiol levels were not signi...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Stein, R. C., Dowsett, M., Hedley, A., Gazet, J. C., Ford, H. T., Coombes, R. C.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Nature Publishing Group 1990
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC1971476/
https://ncbi.nlm.nih.gov/pubmed/2145964
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items